Vimarsana
Biggest News Aggregation in the World

Page 44 - Hologic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hologic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hologic Inc Today - Breaking & Trending Today

Five Golden CAFC Patent Cases of 2023 - Vimarsana News

Five Golden CAFC Patent Cases of 2023

As 2023 draws to a close, here’s a gift of five golden Federal Circuit patent cases!  These decisions issued by the U.S. Court of Appeals for the Federal Circuit (CAFC) significantly impact patent practitioners in several areas, including patent prosecution, litigation, and inter partes reviews (IPRs).

Hologic (NASDAQ:HOLX) Updates Q1 2024 Earnings Guidance - Vimarsana News

Hologic (NASDAQ:HOLX) Updates Q1 2024 Earnings Guidance

Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its first quarter 2024 earnings guidance on Monday morning. The company provided EPS guidance of 0.920-0.970 for the period, compared to the consensus EPS estimate of 0.950. The company issued revenue guidance of $960.0 million-$985.0 million, compared to the consensus revenue estimate of $1.0 billion. […]

Cancer Biopsy Market Surpass $67.11 billion by 2030 - Exclusive Report by Coherent Market Insights - Vimarsana News

Cancer Biopsy Market Surpass $67.11 billion by 2030 - Exclusive Report by Coherent Market Insights

/PRNewswire/ -- According to Coherent Market Insights, The global cancer biopsy market was valued at US$ 25.61Billion in 2023 and is forecast to reach a value...

Stool Testing Market to grow by USD 445.95 million from 2023 to 2028; North America to account for 40% of market growth- Technavio - Vimarsana News

Stool Testing Market to grow by USD 445.95 million from 2023 to 2028; North America to account for 40% of market growth- Technavio

/PRNewswire/ -- The stool testing market is expected to grow by USD 445.95 million from 2023 to 2028. In addition, the momentum of the market will progress at...

Hologic (NASDAQ:HOLX) Lifted to Buy at StockNews.com - Vimarsana News

Hologic (NASDAQ:HOLX) Lifted to Buy at StockNews.com

StockNews.com upgraded shares of Hologic (NASDAQ:HOLX – Free Report) from a hold rating to a buy rating in a report released on Tuesday. Other equities research analysts have also recently issued reports about the stock. Royal Bank of Canada reduced their target price on shares of Hologic from $74.00 to $72.00 and set a sector […]